Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Physiologically, we are different
BPC157 is not FDA-approved for human use in the United States
Konopleva M, Stiouf I, Estrov Z, Tsao T, Harris D, Munsell M, Leysath C, Zhao S, Jackson CE, Chang S, Sporn M, Andreeff M
Importantly, results also demonstrated that the enhancement effect of LASSS on the c-met binding-affinity of HGF is consistently maintained, even after the removal of un-reacted free LASSS (and any degradation products of LASSS), by an interaction between HGF and LASSS or potentially by specific chemical modification of HGF at a high molar ratio of 1:8000 to HGF (over 1:4000)
Most clinical evidence comes from small studies in Asian markets
US$ 25.64
US$ 22.98
US$ 28.00
US$ 20.70
US$ 21.16
